Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $15.3 Million - $24.8 Million
-1,890,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $4.88 Million - $9.82 Million
730,000 Added 62.93%
1,890,000 $17 Million
Q4 2019

Feb 14, 2020

BUY
$6.53 - $10.72 $7.57 Million - $12.4 Million
1,160,000 New
1,160,000 $11.4 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $11.7 Million - $18.2 Million
-1,900,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $15.4 Million - $29.9 Million
1,900,000 New
1,900,000 $17.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Maplelane Capital, LLC Portfolio

Follow Maplelane Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maplelane Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Maplelane Capital, LLC with notifications on news.